President, Research and Development · NOVAVAX INC (NVAX)

Gregory Glenn

A named executive officer of NOVAVAX in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$24,923,376

Salary $483,443Stock awards $1,206,210

FY2019: $1,875,198

2nd of 5 named executive officers at Novavax by FY2020 total.

5 named officers on file for NOVAVAX, FY2020

Gregory Glenn’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 10 equity grants, each cited to its filing
  • NVAX’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how NOVAVAX’s whole pay program stands against its peers

  • NOVAVAX’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NVAX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 3, 2021 (DEF 14A).

Free

Get Gregory Glenn’s full pay file as a PDF — free

More than this page: up to 10 years of Gregory’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Gregory Glenn compensation by year

NOVAVAX Summary Compensation Table · all 5 fiscal years held
In US dollars, as NOVAVAX reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$441,250$450,000$460,125$470,453$483,443
Bonus$0$0$0$0$0
Stock awards$0$0$0$348,306$1,206,210
Option awards$1,193,920$531,250$1,131,189$819,421$22,859,741
Non-equity incentive$0$229,500$79,142$225,818$362,582
Pension and deferred compensation$0$0$0$0$0
All other$7,500$10,500$11,000$11,200$11,400
Total$1,642,670$1,221,250$1,681,456$1,875,198$24,923,376

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NOVAVAX INC DEF 14A filed May 3, 2021, accession 0001104659-21-060332, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NOVAVAX INC filed document, accession 0001104659-21-060332. Every figure is read from that document and cited to the page and table it appears in. Filed May 3, 2021.

$1.6M
$1.2M
$1.7M
$1.9M
$24.9M
FY16
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU9,300$1,206,210—
Option15,880—$46.00
Option45,444—$5.95
Option165,000—$19.08
Option18,700—$129.70
Option6,257—$27.60

Per the Outstanding Equity Awards at Fiscal Year-End table in NOVAVAX INC's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

NOVAVAX’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Stanley ErckPresident and CEO$48,086,018
Gregory Glenn · this pagePresident, Research and Development$24,923,376
John TrizzinoEVP, Chief Commercial Officer, Chief Business Officer and Interim Chief Financial Officer$21,327,954
John HerrmannEVP, Chief Legal Officer and Corporate Secretary$20,606,814
Gregory CovinoFormer EVP, Chief Financial Officer and Treasurer$1,417,774

The full NOVAVAX compensation record

free company brief

This page is one person within NOVAVAX's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NOVAVAX's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Gregory Glenn's compensation dossier · One-time report. No refunds.